Brief: Hemogenyx Pharmaceuticals Raises £3 Million To Accelerate Clinical Development
28/04/2026 08:08
April 28 (Reuters) - Hemogenyx Pharmaceuticals PLC HEMO.L: HEMOGENYX PHARMA PLC - INSTITUTIONAL FUNDRAISE HEMOGENYX PHARMACEUTICALS PLC - RAISES £3 MILLION TO ACCELERATE CLINICAL DEVELOPMENT HEMOGENYX PHARMACEUTICALS PLC - FUNDS TO ACCELERATE PHASE I CLINICAL TRIALS OF HG-CT-1 Source text: ID:nRSb1094Ca Further company coverage: HEMO.L ((Reuters.Briefs@thomsonreuters.com;))